Pulse Biosciences Presents Data From Several Clinical Studies of Nano-Pulse Stimulation Technology to Clear Skin Lesions at the 2019 ASDS Annual Meeting

Posted in Biotech by Medtech[y] Staff

October 18, 2019 • 2 min read

Pulse Biosciences, Inc. (Nasdaq: PLSE), a novel bioelectric medicine company bringing to market its proprietary CellFX System harnessing Nano-Pulse Stimulation (NPS) technology, today announced that it will present results of three clinical studies demonstrating high clearance rates across its benign skin lesion portfolio during the upcoming American Society for Dermatologic Surgery (“ASDS”)...

The Bristol-Myers Squibb-Pfizer Alliance and Fitbit Collaborate to Address Gaps in Atrial Fibrillation Detection with the Aim of Accelerating Diagnosis

Posted in Biotech and Future of Healthcare by Medtech[y] Staff

October 17, 2019 • 2 min read

​The Bristol-Myers Squibb-Pfizer Alliance and Fitbit today announced at the TIME 100 Health Summit in New York that they are working together to help drive timely diagnosis of atrial fibrillation (AFib) with the aim of improving earlier detection in individuals at increased risk of stroke....

Synaptive Medical Expands Availability of Modus V into Spine Market

Posted in Medical Device by Medtech[y] Staff

October 17, 2019 • 2 min read

​Synaptive Medical, a leader in automation and robotics, announced today a strategic commercial expansion into the spinal surgery market. As part of this expansion, Synaptive is also announcing a co-marketing collaboration with Stryker’s Advanced Guidance Technologies business for the company’s robotically controlled digital microscope, Modus V....

Independent Drug-Pricing Assessment Finds Vascepa Cost-Effective as an Adjunct to Statins in Treating Patients at High Risk of Cardiovascular Events, such as Heart Attack, Stroke and Cardiac Death

Posted in Biotech by Medtech[y] Staff

October 17, 2019 • 2 min read

Amarin Corporation plc (NASDAQ: AMRN), a pharmaceutical company focused on improving cardiovascular health, today announced that an independent organization that evaluates pricing of prescription drugs has issued its final report assessing the cost-effectiveness of Vascepa (icosapent ethyl) capsules...

Alexion to Acquire Achillion

Posted in Biotech by Medtech[y] Staff

October 16, 2019 • 4 min read

Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) and Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) today announced that they have entered into a definitive agreement for Alexion to acquire Achillion,...

Discuss Humana Layoffs Anonymously on Medtechy

Posted in Hospitals by Medtech[y] Staff

October 15, 2019 • 2 min read

​Medtechy​ has grown into a platform that provides the latest news on medical device and biotech companies, offers jobs for those in medical device and biotech sales, and even has our own Medtechy store which offers great gadgets and professional courses for our visitors. ...